Barbara Fiorini
Novo Holdings A S
Assets Managed
$1.234B
Holdings
22
Last Quarter
2026 - Q1
Filed Date
1mo 4d ago
Growth Rate
-4.15%(2Q avg: -10.58%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Novo Holdings A S's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 22 positions.
Assets under management
The assets under management (AUM) of Novo Holdings A S over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.234B in assets, with a quarterly growth rate of -4.15% and a 2-quarter average growth rate of -10.58%. The portfolio is managed by Barbara Fiorini, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
EWTX Edgewise Therapeutics Inc
| 13.66% | $168.525M 5.35M shares@ $31.5 avg price | |
BN Brookfield Corp
| 11.47% | $141.493M 3.496M shares@ $40.47 avg price | |
ASML Asml Holding Nv-ny Reg Shs
| 10.17% | $125.408M 94,946 shares@ $1320.83 avg price | Decreased -16.67% |
MIRM Mirum Pharmaceuticals Inc
| 9.92% | $122.404M 1.325M shares@ $92.38 avg price | Increased 4.83% |
MPLT Maplight Therapeutics Inc
| 6.08% | $74.949M 3.687M shares@ $20.33 avg price | |
CRM Salesforce Inc
| 5.95% | $73.396M 393,187 shares@ $186.67 avg price | Increased 19.09% |
CRNX Crinetics Pharmaceuticals In
| 4.57% | $56.296M 1.55M shares@ $36.32 avg price | Decreased -4.61% |
ELVN Enliven Therapeutics Inc
| 4.07% | $50.176M 1.28M shares@ $39.2 avg price | Decreased -13.51% |
PCVX Vaxcyte Inc
| 4.05% | $49.975M 860,000 shares@ $58.11 avg price | Decreased -6.12% |
PHVS Pharvaris Nv
| 4.01% | $49.438M 1.75M shares@ $28.25 avg price |
1-10 of 22